Trial Profile
A Double-blind, Randomized, Placebo-controlled, Three-way Crossover Study to Investigate the Drug-Drug Interactions of Brivaracetam and Ethanol in Healthy Male Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Oct 2018
Price :
$35
*
At a glance
- Drugs Brivaracetam (Primary) ; Alcohol
- Indications Epilepsy
- Focus Therapeutic Use
- Sponsors UCB Pharma SA
- 14 Nov 2012 New trial record
- 01 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.